Bioimpedance Measuring Devices Market

Bioimpedance measuring devices are used for estimating body composition. They measure the body fat in relation to lean body mass. These devices are based on the technology of passing a bioelectrical current through the body. The bioelectrical current estimates the body fluid with the help of resistance data, which the bioelectrical current endures in the body tissue.
Bioimpedance Measuring Devices Market contains market size and forecasts of Bioimpedance Measuring Devices in global, including the following market information:
Global Bioimpedance Measuring Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bioimpedance Measuring Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Bioimpedance Measuring Devices companies in 2021 (%)
The global Bioimpedance Measuring Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single-frequency Bioimpedance Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bioimpedance Measuring Devices include General Electric, Omron, Fresenius Medical Care, ImpediMed, SELVAS, Tanita, RJL Systems, Maltron International and Bodystat and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bioimpedance Measuring Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bioimpedance Measuring Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bioimpedance Measuring Devices Market Segment Percentages, by Type, 2021 (%)
Single-frequency Bioimpedance Devices
Multiple-frequency Bioimpedance Devices
Global Bioimpedance Measuring Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bioimpedance Measuring Devices Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Rehabilitation Centers
Others
Global Bioimpedance Measuring Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bioimpedance Measuring Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bioimpedance Measuring Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bioimpedance Measuring Devices revenues share in global market, 2021 (%)
Key companies Bioimpedance Measuring Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Bioimpedance Measuring Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
General Electric
Omron
Fresenius Medical Care
ImpediMed
SELVAS
Tanita
RJL Systems
Maltron International
Bodystat
Akern